Javascript Menu by Deluxe-Menu.com

Advanced Search
  Home Breaking News Newsletters Books & Reports Events Jobs Editorial Board Interviews e-Alert Contact Us
  Privacy Awards & Scholarships Advertising G-2 Advisory Services Blogs & Online Resources List Rentals
Diagnostic Imaging & Intelligence   •   G2 Compliance   •   Laboratory Industry   •   National Intelligence    •    Diagnostic Testing & Technology  
     
 
Diagnostic Testing & Technology Report

H1N1 Flu Testing Volume Down 75% Since October
January 2010

Influenza activity across the United States decreased sharply in November and December, according to surveillance data from the Centers for Disease Control and Prevention (CDC). During the week of Dec. 6, 7 percent of specimens tested by U.S. World Health Organization and National Respiratory and Enteric Virus Surveillance System collaborating laboratories and reported to CDC were positive for influenza. However, the 2009 influenza A (H1N1) virus remains dominant. More than 99 percent of all subtyped influenza A viruses reported to the CDC in that period were 2009 influenza A (H1N1) viruses.


At Quest Diagnostics (Madison, N.J.), H1N1 testing volume declined by 75 percent between the peak week of Oct. 22-28 and the week of Dec. 3-9, when it returned to August levels. Quest also reported decreased positivity rates. About half of the 170,000 patient samples processed by the laboratory company between May 11 and Dec. 9 tested positive for H1N1. In November, that proportion dropped to 44 percent and for the two weeks ending Dec. 9, only 21 percent of specimens tested positive. For more on H1N1 flu trends, see Inside the Diagnostics Industry.

January 2010 - Table of Contents
DTTR January 2010 (Full PDF Issue)
H1N1 Flu Testing Volume Down 75% Since October
Becton Dickinson Completes $275 Million Acquisition of HandyLab
deCODE Genetics Files for Bankruptcy
FDA Authorizes Emergency Use of H1N1 Flu Tests from Roche, DxNA, TessArae
Gen-Probe Receives FDA Clearance for Prodesse Parainfluenza Test
Medicare Finalizes Decision to Cover HIV Screening
Inside the Diagnostics Industry: H1N1 Virus Activity and Testing Volumes Down From Fall High, but Labs Remain Vigilant
Lab Test Volumes Climb in 2009, G-2 Survey Finds
Cystic Fibrosis Screening Linked to Decreased Disease Incidence
Life Technologies Completes Purchase of BioTrove
Clarient Acquires Applied Genomics
Screening Test Can Identify Newborns With Blood Disorder, JAMA Study Finds
Genetic Findings May Translate to New Test for Lung Cancer
BD Receives Expanded Clearance for STD Tests
IVD Stocks Gain 6%; OraSure Up 20% on Medicare Decision to Cover HIV Testing
G2 Insider (January 2010)

Archives

 
     
  Home Privacy Awards & Scholarships Editorial Board Contact Us Advertising G-2 Advisory Services Blogs & Online Resources List Rentals

Copyright © 1999-2010 Washington G-2 Reports. No portion of the material presented on this site may be used without express written permission from authorized personnel at Washington G-2 Reports. Washington G-2 Reports is an operating unit of IOMA, the Institute of Management & Administration, Inc.